Globe Life's CEO Frank Svoboda Purchases 10,000 Shares

Frank Svoboda, the Co-Chairman and CEO of Globe Life Inc., made a significant purchase of company shares recently. On June 11, 2026, Svoboda acquired 10,000 shares of Globe Life stock at an average price of $100.74 per share, amounting to a total transaction value of approximately $1.01 million. This purchase was not part of a pre-planned trading program, indicating personal confidence in the company's prospects.

Insider Buying and Selling at Globe Life Inc.

Frank Svoboda has been active in trading Globe Life shares. Alongside his recent purchase, he also sold shares on June 11 and 12, 2026, at various prices, including $166.68 and $164.89 per share. These transactions highlight a dynamic approach to managing his holdings in the company.

Other Institutional Activity in Globe Life

Several large funds have also adjusted their positions in Globe Life. BlackRock, Inc. trimmed its holdings by 146,546 shares, ending with 5,542,531 shares valued at $771.35 million. Vanguard Capital Management LLC initiated a new position with 5,149,992 shares worth $716.72 million. Vanguard Portfolio Management LLC also started a new position, acquiring 4,254,103 shares valued at $592.04 million. Invesco Ltd. increased its stake by 67,674 shares to a total of 4,016,350 shares, valued at $558.96 million. State Street Corp saw a significant increase, adding 485,155 shares to hold 3,658,664 shares worth $509.18 million.

Globe Life Inc. Stock Snapshot

Shares of Globe Life Inc. (NYSE:GL) recently traded around $166.76. The company has a market capitalization of approximately $12.95 billion and a P/E ratio of 11.53. Its stock has seen a 52-week range from $116.73 to $168.27 and maintains a 50-day moving average of $152.97 and a 200-day moving average of $142.41. The stock's beta is relatively low at 0.499, indicating less volatility compared to the broader market.

Recent Earnings

Globe Life reported revenues of $6.07 billion, reflecting a growth rate of 5.4%. The company achieved a net margin of 19.38% and a return on equity of 20.46%. Earnings per share stood at $14.46. Investors can look forward to the next earnings report, scheduled for July 22, 2026.

Dividend

Globe Life offers an annual dividend rate of $1.32, yielding 0.79%. The dividend payout ratio is a conservative 7.89%, indicating a sustainable distribution policy.

Analysts Set New Price Targets

Analysts have been bullish on Globe Life, with several firms maintaining 'buy' ratings. On May 26, 2026, Piper Sandler reiterated its 'buy' rating with a price target of $175. Morgan Stanley followed suit on May 21, 2026, with a target of $181. Truist Securities maintained its 'buy' rating with a target of $185. The consensus among 11 analysts remains 'buy', with a mean price target of $175.91.

About Globe Life Inc.

Globe Life Inc., based in McKinney, Texas, provides life and supplemental health insurance products primarily to middle-income families in the United States. Operating through segments like Life Insurance and Supplemental Health Insurance, the company offers a range of products, including whole and term life insurance, Medicare supplements, and various health insurance plans. Globe Life sells its products via direct-to-consumer channels and independent agents. Founded in 1900 and formerly known as Torchmark Corporation, the company rebranded to Globe Life Inc. in August 2019.

Bottom Line

Frank Svoboda's recent purchase of Globe Life shares underscores his confidence in the company's future. Globe Life continues to attract institutional interest, with major funds adjusting their stakes. Analysts remain positive, maintaining 'buy' ratings and setting favorable price targets. As always, it's important to remember that insider transactions and analyst ratings are just part of the broader picture investors consider when evaluating a stock.